Week In Review: Illumina Pays $8 Billion To Acquire GRAIL, An Early-Stage Cancer Testing Company
September 26, 2020 at 14:33 PM EDT
Illumina will acquire Grail, an Illumina spin-out that is developing an early screening test for multiple forms of cancer, for $8 billion in cash and stock. JD Health, a Beijing online healthcare company, plans to raise $3 billion in a Hong Kong IPO.
